PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,031 | +273.3% | 13,725 | +433.8% | 0.00% | – |
| Q2 2023 | $2,419 | +7459.4% | 2,571 | -92.2% | 0.00% | -100.0% |
| Q1 2023 | $32 | -46.7% | 33,049 | -24.2% | 0.00% | -50.0% |
| Q4 2022 | $60 | -99.9% | 43,596 | +4.7% | 0.00% | +100.0% |
| Q3 2022 | $52,000 | +2.0% | 41,625 | +89.9% | 0.00% | 0.0% |
| Q2 2022 | $51,000 | +6.2% | 21,919 | +41.2% | 0.00% | – |
| Q1 2022 | $48,000 | +380.0% | 15,523 | +865.4% | 0.00% | – |
| Q4 2021 | $10,000 | -54.5% | 1,608 | -26.1% | 0.00% | -100.0% |
| Q3 2021 | $22,000 | -72.8% | 2,177 | -64.6% | 0.00% | -50.0% |
| Q2 2021 | $81,000 | +47.3% | 6,142 | +97.0% | 0.00% | +100.0% |
| Q1 2021 | $55,000 | +139.1% | 3,118 | +250.7% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -85.8% | 889 | -92.8% | 0.00% | -50.0% |
| Q3 2020 | $162,000 | +671.4% | 12,382 | +1508.1% | 0.00% | +100.0% |
| Q2 2020 | $21,000 | +950.0% | 770 | +427.4% | 0.00% | – |
| Q1 2020 | $2,000 | – | 146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |